Histogen Inc (HSTO)
0.10
-0.25
(-71.52%)
USD |
OTCM |
May 01, 09:46
Histogen 1 Year Total Returns (Daily): -57.73% for April 30, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 30, 2024 | -57.73% |
April 29, 2024 | -57.73% |
April 26, 2024 | -61.54% |
April 25, 2024 | -63.16% |
April 24, 2024 | -63.15% |
April 23, 2024 | -64.23% |
April 22, 2024 | -64.23% |
April 19, 2024 | -85.84% |
April 18, 2024 | -52.83% |
April 17, 2024 | -59.02% |
April 16, 2024 | -52.38% |
April 15, 2024 | -52.38% |
April 12, 2024 | -50.98% |
April 11, 2024 | -54.96% |
April 10, 2024 | -58.33% |
April 09, 2024 | -55.75% |
April 08, 2024 | -55.75% |
April 05, 2024 | -56.52% |
April 04, 2024 | -58.33% |
April 03, 2024 | -57.98% |
April 02, 2024 | -58.68% |
April 01, 2024 | -70.24% |
March 28, 2024 | -68.13% |
March 27, 2024 | -65.81% |
March 26, 2024 | -65.81% |
Date | Value |
---|---|
March 25, 2024 | -66.67% |
March 22, 2024 | -72.46% |
March 21, 2024 | -70.37% |
March 20, 2024 | -76.60% |
March 19, 2024 | -75.19% |
March 18, 2024 | -75.19% |
March 15, 2024 | -63.13% |
March 14, 2024 | -63.84% |
March 13, 2024 | -57.61% |
March 12, 2024 | -58.95% |
March 11, 2024 | -63.16% |
March 08, 2024 | -69.16% |
March 07, 2024 | -63.89% |
March 06, 2024 | -58.51% |
March 05, 2024 | -64.89% |
March 04, 2024 | -62.77% |
March 01, 2024 | -66.84% |
February 29, 2024 | -68.81% |
February 28, 2024 | -68.81% |
February 27, 2024 | -68.56% |
February 26, 2024 | -69.17% |
February 23, 2024 | -69.74% |
February 22, 2024 | -69.23% |
February 21, 2024 | -61.90% |
February 20, 2024 | -70.04% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-94.79%
Minimum
Sep 24 2019
54.17%
Maximum
Jun 29 2020
-70.67%
Average
-74.41%
Median
Jul 21 2021
1 Year Total Returns (Daily) Benchmarks
CEL-SCI Corp | -30.81% |
AIM ImmunoTech Inc | -14.90% |
IGC Pharma Inc | 57.10% |
NovaBay Pharmaceuticals Inc | -92.97% |
Protalix BioTherapeutics Inc | -58.99% |